azacitidine has been researched along with Papillomavirus Infections in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baguet, A; Demeret, C; Guenat, D; Jacquin, E; Morel, A; Mougin, C; Perrard, J; Prétet, JL | 1 |
Bellinger, G; Bhatia, A; Biktasova, A; Burtness, B; Deshpande, HA; Gary, C; Hajek, M; Issaeva, N; Judson, B; Mehra, S; Sewell, A; Yarbrough, WG | 1 |
Chu, TY; Ding, DC; Huang, RL; Lin, CJ; Liu, CJ; Liu, DW; Wang, KH; Weng, CF | 1 |
Chan, AW; Chan, MW; Chan, PK; Lee, TL; Lo, KW; To, KF; Tong, JH; Yu, MY | 1 |
Bachmann, A; Rösl, F; Zawatzky, R | 1 |
Bieblova, J; Bubenik, J; Hejnar, J; Indrova, M; Jandlova, T; Lubyova, B; Manning, J; Pribylova, H; Reinis, M; Simova, J | 1 |
6 other study(ies) available for azacitidine and Papillomavirus Infections
Article | Year |
---|---|
5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression.
Topics: Azacitidine; Cell Line, Tumor; Decitabine; DNA Methylation; Female; Gene Expression Regulation, Viral; Human papillomavirus 16; Humans; MicroRNAs; Oncogene Proteins, Viral; Papillomavirus Infections; Repressor Proteins; Up-Regulation; Uterine Cervical Neoplasms | 2017 |
Demethylation Therapy as a Targeted Treatment for Human Papillomavirus-Associated Head and Neck Cancer.
Topics: Animals; Apoptosis; Azacitidine; Carcinoma, Squamous Cell; Cell Line, Tumor; DNA Methylation; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Mice, Nude; Papillomaviridae; Papillomavirus Infections; Xenograft Model Antitumor Assays | 2017 |
Global methylation silencing of clustered proto-cadherin genes in cervical cancer: serving as diagnostic markers comparable to HPV.
Topics: Adult; Antimetabolites, Antineoplastic; Azacitidine; Biomarkers, Tumor; Cadherins; Cell Adhesion; Cell Line, Tumor; CpG Islands; Disease Progression; DNA Methylation; Female; Gene Silencing; Genetic Loci; Humans; Middle Aged; Multigene Family; Neoplasm Invasiveness; Neoplasm Staging; Papillomaviridae; Papillomavirus Infections; Severity of Illness Index; Uterine Cervical Neoplasms | 2015 |
Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
Topics: Adenocarcinoma; Adult; Aged; Azacitidine; Carcinoma, Squamous Cell; Chromosomes, Human, Pair 3; DNA Methylation; DNA Primers; DNA, Neoplasm; DNA, Viral; Enzyme Inhibitors; Female; Gene Silencing; Genes, Tumor Suppressor; Humans; Loss of Heterozygosity; Middle Aged; Mutation; Neoplasm Proteins; Neoplasm Staging; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Tumor Cells, Cultured; Tumor Suppressor Proteins; Tumor Virus Infections; Uterine Cervical Neoplasms | 2003 |
Genetic redundancy in human cervical carcinoma cells: identification of cells with "normal" properties.
Topics: Animals; Azacitidine; Butyrates; Cardiovirus Infections; Decitabine; DNA Methylation; Encephalomyocarditis virus; Female; HeLa Cells; Histone Deacetylase Inhibitors; Human papillomavirus 18; Humans; Immunocompromised Host; Interferon Regulatory Factor-1; Interferon-beta; Interferon-Stimulated Gene Factor 3, gamma Subunit; Mice; Mice, Nude; Papillomavirus Infections; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms | 2007 |
Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen-processing machinery components in a murine model for human papilloma virus 16-associated tumours.
Topics: Animals; Antigen Presentation; Apoptosis; Azacitidine; Enzyme Inhibitors; Epigenesis, Genetic; Genes, MHC Class I; Histones; Human papillomavirus 16; Humans; Hydroxamic Acids; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Papillomavirus Infections; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured; Up-Regulation | 2008 |